Romina Estefanía Nieto, Graciela S Alarcón, Laurent Arnaud, Guillermo Javier Pons-Estel
{"title":"Finding the Role of Anifrolumab in the New Paradigm of Systemic Lupus Erythematosus Treatment.","authors":"Romina Estefanía Nieto, Graciela S Alarcón, Laurent Arnaud, Guillermo Javier Pons-Estel","doi":"10.3899/jrheum.2024-0900","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3899/jrheum.2024-0900","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
Tani 等人的文章《阿尼单抗治疗难治性系统性红斑狼疮：一项真实世界的多中心研究》1 评估了阿尼单抗（ANI）对治疗无效的系统性红斑狼疮（SLE）患者的疗效：一项真实世界的多中心研究 "1 评估了阿尼单抗（ANI）对其他治疗方法（包括生物制剂）无效的系统性红斑狼疮（SLE）患者的疗效。尽管最近取得了一些进展，但缓解率和低疾病活动率（LDA）仍未达到最佳水平；因此，一些系统性红斑狼疮患者极有可能罹患终末期肾病、器官损害、药物相关毒性（尤其是与长期使用糖皮质激素（GCs）有关）以及过早死亡。
期刊介绍：
The Journal of Rheumatology is a monthly international serial edited by Earl D. Silverman. The Journal features research articles on clinical subjects from scientists working in rheumatology and related fields, as well as proceedings of meetings as supplements to regular issues. Highlights of our 41 years serving Rheumatology include: groundbreaking and provocative editorials such as "Inverting the Pyramid," renowned Pediatric Rheumatology, proceedings of OMERACT and the Canadian Rheumatology Association, Cochrane Musculoskeletal Reviews, and supplements on emerging therapies.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
